Skip to content
Search for:
ABOUT
MANAGEMENT
BOARD OF DIRECTORS
SCIENTIFIC ADVISORY BOARD
PIPELINE
ENVAFOLIMAB (KN035)
TRC102
TRC253
TJ004309
CLINICAL TRIALS
PARTNERS
NEWS
PRESS RELEASES
PUBLICATIONS
VIDEO PRESENTATIONS
INVESTORS
PRESS RELEASES
EVENTS & PRESENTATIONS
CORPORATE GOVERNANCE
FINANCIALS & FILINGS
SEC FILINGS
ANNUAL REPORTS & PROXIES
QUARTERLY REPORTS
STOCK INFORMATION
HISTORICAL PRICE LOOKUP
INVESTMENT CALCULATOR
INVESTOR FAQ
CONTACT
CONTACT
COMMUNITY
Classic Home
admin
2020-05-30T23:50:01+00:00
OUR GOAL IS TO BE A LEADER IN THE DEVELOPMENT OF TARGETED THERAPIES FOR PATIENTS WITH CANCER AND OTHER DISEASES OF HIGH UNMET NEED
Go to Top